#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness Cystic fibrosis gastrointestinal disease X-linked lymphoproliferative syndrome Piriformis syndrome Deafness bilateral Neoplasm malignant Follicle centre lymphoma follicular grade I II – III refractory Diffuse large B-cell lymphoma Myxofibrosarcoma Philadelphia chromosome positive Hepatic angiosarcoma Lip and/or oral cavity cancer Transplant rejection Acute myeloid leukaemia (in remission) Dermatitis More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Basic Information Cystic fibrosis Andersen-Tawil syndrome – Life with Disease Haemophilia A without inhibitors – Trials in Disease SAPHO syndrome – Diagnostics Rhabdoid tumour – Trials in Disease Erdheim-Chester disease – Treatment Retinitis pigmentosa Hereditary motor and sensory neuropathy – Diagnostics Tuberous sclerosis complex – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Somatropin Ixazomib Mexiletine Sabatolimab Lisocabtagene Maraleucel Brentuximab Vedotin Buloxibutid Acetazolamide AUROCELL-TX Eteplirsen Rbl015.2 Dacarbazine Citrate His203-Crm197 Quc398 Alx148 Tub-040 Dupilumab Sodium Phosphate Dodecahydrate Almagate Odronextamab More therapies…

    Learn about Your Condition

    Ocular lymphoma Cystic fibrosis Choroidal neovascularisation Advanced systemic mastocytosis Alopecia areata Pancreatitis chronic Palmoplantar pustulosis Pyelonephritis acute Immune system disorder Rhinitis allergic Breast neoplasm Coronary artery occlusion Laryngeal cancer stage II Follicular lymphoma stage IV Breast cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ventricular tachycardia

  • Study of AGP100 Safety and Effectiveness in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    Recruiting

    2 1 1
    Norway
  • Study on the Safety and Effects of CRD-4730 for Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    Recruiting

    2 1
    Investigated Diseases:
    • Ventricular tachycardia
    Investigated Drugs:
    • Crd-4730
    France Italy The Netherlands Spain
  • Comparison of Carvedilol and Flecainide Treatment in Patients with Idiopathic Ventricular Arrhythmias

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ventricular extrasystoles
    • Ventricular tachycardia
    Investigated Drugs:
    • Flecainide
    • Carvedilol
    Spain
  • Study on the Safety of CRD-4730 for Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    Not recruiting

    2 1
    Investigated Diseases:
    • Ventricular tachycardia
    Investigated Drugs:
    • Crd-4730
    France Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!